Note: Jubilant Draximage Radiopharmacies's revenues are gauged from an analysis of company filings.
Jubilant Draximage Radiopharmacies's Income Statement (based on Industry Averages)
Jubilant Draximage Radiopharmacies P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Jubilant Draximage Radiopharmacies is developing and marketing.
Jubilant Draximage Radiopharmacies doesn't have any recent trademark applications, indicating Jubilant Draximage Radiopharmacies is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
TRIAD ISOTOPES Nuclear pharmaceutical products for clinical and medical use in diagnostic and therapeutic diagnostic procedures and treatments, namely, PET imaging, nuclear oncology testing and treatments, nuclear cardiology testing and treatments, and bracytherapy testing and treatments
10/05/2007
TRIAD ISOTOPES PATIENT FOCUSED. COMMUNITY DRIVEN. Nuclear pharmaceutical products for clinical and medical use in diagnostic and therapeutic diagnostic procedures and treatments, namely, PET imaging, nuclear oncology testing and treatments, nuclear cardiology testing and treatments, and bracytherapy testing and treatments
10/05/2007
See all trademarks and details in the Full Report.
Market Share of Jubilant Draximage Radiopharmacies's Largest Competitors
A competitive analysis shows these companies are in the same general field as Jubilant Draximage Radiopharmacies, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Jubilant Draximage Radiopharmacies.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Jubilant Draximage Radiopharmacies and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.